The major histocompatibility complex (MHC) plays a crucial role in the immune response by binding to antigens and activating T cells. MHC molecules are essential for antigen presentation, which is a key process in both the innate and adaptive immune systems. This summary focuses on MHC class I, which is specifically responsible for activating cytotoxic T cells (TC cells).
MHC class I consists of a single polypeptide chain associated with a protein called beta-2 microglobulin. Together, they form a peptide binding site that accommodates an 8 to 10 amino acid sequence from an antigen. The process of antigen presentation via MHC class I involves several steps, particularly in the context of intracellular pathogens.
First, an intracellular pathogen, such as a virus, is present in the cytosol of an infected cell. This pathogen can originate from a cell that has been infected or from viral genes expressed within the cell. To eliminate the pathogen, it is tagged with ubiquitin and directed to the proteasome for degradation. This process, known as the ubiquitin-proteasome pathway, breaks down the pathogen into smaller peptide fragments.
Once degraded, these peptide fragments are transported into the endoplasmic reticulum (ER) through a specialized transport mechanism called the TAP complex. Inside the ER, the peptides bind to MHC class I molecules. After this binding occurs, the MHC class I-peptide complex is transported to the plasma membrane of the cell.
Finally, the MHC class I complex is expressed on the cell surface, where it can activate cytotoxic T cells. This activation is critical for the immune response, as it enables TC cells to recognize and destroy infected cells, thereby playing a vital role in the body's defense against intracellular pathogens.